China Sell API 99% CAS61177-45-5 Clavulanate Potassium From Sinophar M

Name: China Sell API 99% CAS61177-45-5 Clavulanate Potassium From Sinophar M
Brand: Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd.
SKU: 1909951092

Fujian, ChinaFuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd.

US$2.50

1,000 kg

Sample price:US$30.00/piece.Request sample

Product profile

Powder

Yes

Customized

Certification

GMP, ISO 9001, USP, BP

Model NO.

Clavulanate-006

Suitable for

Elderly, Children, Adult

State

Solid

Purity

≦96%

Application

Penicillin Antibacterial

Usage Mode

API

Shape

Powder

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Transport Package

2kg/25kg Per

Specification

2kg

Trademark

Ful

Origin

China

HS Code

3004101200

Production Capacity

1billion/Year

Company profile

Fuzhou FUL Fluid Equipment & Pharmaceutical Co., Ltd.Fujian, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedCustomization Options: Customization from SamplesExport Year: 2008-01-01 CertifiedNearest Port: Fuzhou PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T

AI-Powered supplier vetting

SummaryThe supplier is a biotechnology and pharmaceutical equipment enterprise engaged in equipment R&D, production, construction, biotechnology development and transfer, and cooperative drug and vaccine production. Its stated product scope is medical fluid equipment, with related keywords covering pharmaceutical and vaccine production lines, intermediates, APIs, and finished drug preparations. It has a 5,000 m² manufacturing plant and exports 41%–50% of total sales, including through agents. Evidence indicates quality assurance, but no written procedures or records for service assessment, corrective and preventive actions, or complaint handling. The supplier does not provide ODM, 3D software design, SDKs, overseas warehouses, overseas showrooms, overseas agents or branches, and has not attended offline trade shows. It offers sample-based customization. Financial records are indicated for 2022–2024, but no assessable financial figures are provided.

Supplier typeThe supplier is described as a comprehensive biotechnology and pharmaceutical equipment enterprise integrating R&D, production, construction, biotechnology transfer, and cooperative drug and vaccine production. Its stated product scope is medical fluid equipment, supported by keywords covering pharmaceutical and vaccine production lines and related pharmaceutical products.

After-Sales capabilityThe supplier has no written procedures or records for service-capability assessment, corrective and preventive actions, or effective customer-complaint handling. It also reports no overseas warehouse, showroom, overseas agent or branch, while its stated peak- and off-season lead time is one month.

R&D capabilityThe supplier reports no professional technical-supplier R&D capability, no 3D software design service, no available SDK, no ODM service, and no new products during the past year. Its company description does mention R&D and biotechnology development, but the explicit capability responses indicate limited demonstrated innovation services.

Production capacityThe supplier states that it integrates equipment production and construction and operates a 5,000 m² manufacturing plant. Its business and product information is aligned with pharmaceutical and medical fluid equipment, although the provided slices do not quantify production capacity, equipment, or output.

Customization capabilityThe supplier explicitly provides customization from samples, demonstrating a sample-based customization capability. No evidence is provided for broader engineering, ODM, or 3D-design customization, and ODM is explicitly unavailable.